Pharmacy Management

The Pfizer announcement late last year, of its intention to distribute directly to pharmacy through DHL, has created quite a stir in the industry.  Feedback from pharmacists and the wholesalers has been predominantly negative, and many were vocal in their condemnation of the move at conference sessions.

However, despite the obvious negative results to wholesaling companies, there is limited anecdotal evidence of the resultant impact to pharmacy practices.  In an open forum, Dr Martin Cross referred to pharmacists to determine the outcome of the Pfizer move - indicating that the response of pharmacists will determine if the Pfizer move is a success or not.

The Pfizer announcement late last year, of its intention to distribute directly to pharmacy through DHL, has created quite a stir in the industry.  Feedback from pharmacists and the wholesalers has been predominantly negative, and many were vocal in their condemnation of the move at conference sessions.

However, despite the obvious negative results to wholesaling companies, there is limited anecdotal evidence of the resultant impact to pharmacy practices.  In an open forum, Dr Martin Cross referred to pharmacists to determine the outcome of the Pfizer move - indicating that the response of pharmacists will determine if the Pfizer move is a success or not.